These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 444681)

  • 1. [Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].
    Labedzki L; Illiger HJ
    Blut; 1979 May; 38(5):421-4. PubMed ID: 444681
    [No Abstract]   [Full Text] [Related]  

  • 2. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
    Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic myelomonocytic leukaemia: a case report.
    Gétaz EP; Staples WG
    S Afr Med J; 1977 Jun; 51(23):852-3. PubMed ID: 267330
    [No Abstract]   [Full Text] [Related]  

  • 4. Etoposide in the treatment of acute leukemia in adults.
    Varini M; Cavalli F; Sauter C
    Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
    [No Abstract]   [Full Text] [Related]  

  • 5. Etoposide (VP-16-213).
    Issell BF; Crooke ST
    Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
    [No Abstract]   [Full Text] [Related]  

  • 6. Etoposide (VP-16-213). Current status of an active anticancer drug.
    O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
    N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.
    Rivera G; Bowman WP; Look AT; Evans WE; Kalwinsky D; Dahl GV
    Cancer Treat Rev; 1982 Jun; 9 Suppl():53-7. PubMed ID: 6181873
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.
    Chard RL; Krivit W; Bleyer WA; Hammond D
    Cancer Treat Rep; 1979; 63(11-12):1755-9. PubMed ID: 294306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid remission induction in adult acute non-lymphoblastic leukaemia.
    Dubovsky D; Kernoff L; Jacobs P
    Eur J Cancer (1965); 1978 Nov; 14(11):1179-83. PubMed ID: 738325
    [No Abstract]   [Full Text] [Related]  

  • 11. Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia.
    Kucuk O; Apostol JV
    J Surg Oncol; 1985 Mar; 28(3):172-3. PubMed ID: 3856083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].
    Schmoll HJ; Niederle N; Achterrath W
    Klin Wochenschr; 1981 Nov; 59(21):1177-88. PubMed ID: 7031350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New antineoplastic drugs of the podophyllotoxin derivative group].
    Robak T; Płuzańska A
    Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.
    Look AT; Dahl GV; Rivera G; Mauer AM
    Cancer Chemother Pharmacol; 1982; 7(2-3):161-7. PubMed ID: 6177437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K; Yamada K; Yoshida T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP-16-213 (etoposide): the mandrake root from Issyk-Kul.
    Vogelzang NJ; Raghavan D; Kennedy BJ
    Am J Med; 1982 Jan; 72(1):136-44. PubMed ID: 6277188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
    Lazarus HM; Creger RJ; Diaz D
    Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis.
    Thomas MR; Robinson WA; Mughal TI; Glode LM
    Am J Hematol; 1984 Feb; 16(2):185-8. PubMed ID: 6582781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies in relation to drug action.
    Muggia FM; McVie G
    NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
    [No Abstract]   [Full Text] [Related]  

  • 20. Etoposide (VP 16-213; VePesid).
    Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.